[an error occurred while processing this directive] | [an error occurred while processing this directive]
Prognostic analysis of 68 patients with initially diagnosed bone-only metastatic nasopharyngeal carcinoma
Sang Xuejin,Wang Xiaoyan,Yang Zhining,Huang Baotian,Lin Zhixiong
Department of Radiation Oncology,Cancer Hospital,Shantou University Medical College,Shantou 515000,China (Wang DD,Li M,Yang ZHN,Luo R,Xu ZHX,Lin ZHX);Zhongshan City People’s Hospital,Zhongshan 528400,China (Sang XJ)
AbstractObjective To analyze the prognostic factors in patients with initially diagnosed bone-only metastatic nasopharyngeal carcinoma (NPC). Methods We collected the data of 68 patients with initially diagnosed bone-only metastatic NPC admitted to The Affiliated Tumor Hospital of Shantou University Medical College from 1997 to 2015. Forty-nine patients received chemoradiotherapy. The Kaplan-Meier method was used to calculate the overall survival rate;the log-rank test was used for univariate prognostic analysis;the Cox model was used for multivariate prognostic analysis. Results The median follow-up was 95.3 months. The 1-, 2-, 3-, and 5-year overall survival (OS) rates were 53%, 38%, 21%, and 15%, respectively. The median OS time was 13.4 months. The univariate prognostic analysis showed that spinal metastases, the number of bone metastases, lactic dehydrogenase level before treatment, the radiotherapy technology and dose for primary tumor, and the short-term outcome of primary tumor were associated with OS (P=0.02,0.01,0.00,0.02,0.02,0.01). The multivariate prognostic analysis showed that ≤3 bone metastases, dose to primary tumor>65 Gy, and intensity-modulated radiotherapy (IMRT) were favorable prognostic factors for OS (P=0.03,0.02,0.04). Conclusions For patients with initially diagnosed bone-only metastatic NPC, active treatment (IMRT, dose to primary tumor>65 Gy) should be considered for those with ≤3 bone metastases to achieve a complete response of primary tumor.
[1] Chang ET,Adami HO.The enigmatic epidemiology of nasopharyngeal carcinoma[J].Cancer Epidemiol Biomarkers Prev,2006,15(10):1765-1777.DOI:10.1158/1055-9965.EPI-06-0353. [2] 殷蔚伯,余子豪,徐国镇,等.肿瘤放射治疗学[M].4版.北京:中国协和医科大学出版社,2008. Yin WB,Yu ZH,Xu GZ,et al. Radiation Oncology[M].4 ed. Beijing:Peking Union Medical College press,2008. [3] Li AC,Xiao WW,Shen GZ,et al. Distant metastasis risk and patterns of nasopharyngeal carcinoma in the era of IMRT:long-term results and benefits of chemotherapy[J].Oncotarget,2015,6(27):24511-24521.DOI:10.18632/oncotarget.4312. [4] Zeng L,et al. Retrospective analysis of 234 nasopharyngeal carcinoma patients with distant metastasis at initial diagnosis:therapeutic approaches and prognostic factors[J].PLoS One,2014,9(9):e108070.DOI:10.1371/journal.pone.0108070. [5] 蓝玉宏,田允铭,白力,等.初治转移鼻咽癌疗后预后评分模型建立及分层治疗研究[J].中华放射肿瘤学杂志,2015,24(4):421-426.DOI:10.3760/cma.j.issn.1004-4221.2015.04.017. Lan YH,Tian YM,Bai L,et al. Post-treatment prognostic score model establishment and stratified therapy for newly diagnosed metastatic nasopharyngeal carcinoma[J]Chin J Radiat Oncol,2015,24(4):421-426.DOI:10.3760/cma.j.issn.1004-4221.2015.04.017. [6] 韩露,林少俊,李夷民,等.46例首诊伴远处转移鼻咽癌的预后分析[J].中华放射肿瘤学杂志,2009,18(3):170-172.DOI:10.3760/cma.j.issn.1004-4221.2009.03.170. Han L,Lin SJ,Li YM,et al. Therapeutic results of 46 patients with initially diagnosed metastatic nasopharyngeal carcinoma[J].Chin J Radiat Oncol,2009,18(3):170-172.DOI:10.3760/cma.j.issn.1004-4221.2009.03.170. [7] Cao X,Han YJ,He LR,et al. Risk subset of the survival for nasopharyngeal carcinoma patients with bone metastases:who will benefit from combined treatment?[J].Oral Oncol,2011,47(8):747-752.DOI:10.1016/j.oraloncology.2011.05.010. [8] Hui EP,Leung SF,Au JSK,et al. Lung metastasis alone in nasopharyngeal carcinoma:a relatively favorable prognostic group[J].Cancer,2004,101(2):300-306.DOI:10.1002/cncr.20358. [9] 张新明,高伟,潘琪.恶性肿瘤骨转移机制研究进展[J].国际肿瘤学杂志,2011,38(1):67-69.DOI:10.3760/cma.j.issn.1673-422X.2011.01.022. Zhang XM,Gao W,Pan Q.Research progress on mechanisms of bone metastasis of malignant tumors[J].J Int Oncol,2011,38(1):67-69.DOI:10.3760/cma.j.issn.1673-422X.2011.01.022. [10] Ong YK,Heng DM,Chung B,et al. Design of a prognostic index score for metastatic nasopharyngeal carcinoma[J].Eur J Cancer,2003,39(11):1535-1541.DOI:10.1016/S0959-8049(03)00310-1. [11] Shen LJ,Dong J,Li S,et al. M1 stage subdivision and treatment outcome of patients with bone-only metastasis of nasopharyngeal carcinoma[J].Oncologist,2015,20(3):291-298.DOI:10.1634/theoncologist.2014-0206. [12] Andreula C,Murrone M,Algra PR.Metastatic disease of the spine[A].Van Goethem JWM,van den Hauwe L,Parizel PM.Spinal Imaging. Medical Radiology (Diagnostic Imaging)[M].Berlin Heidelberg:Springer,2007:461-474.DOI:10.1007/978-3-540-68483-1_19. [13] Leung KW,Leung JLY,Sy ANL,et al. Bone metastasis as the first presentation of hepatocellular carcinoma[J].J Hk Coll Radiol,2010,12(3):113-116. [14] Uccella S,Morris JM., Bakkum-Gamez JN,et al. Bone metastases in endometrial cancer:report on 19 patients and review of the medical literature[J].Gynecol Oncol,2013,130(3):474-482.DOI:10.1016/j.ygyno.2013.05.010. [15] 朱衍菲,丁轶,陈斌,等.鼻咽癌疗后骨转移程度对预后的影响[J].中华放射肿瘤学杂志,2013,22(4):299-3012.DOI:10.3760/cma.j.issn.1004-4221.2013.04.010. Zhu YF,Ding Y,Chen B,et al. Prognostic impact of degree of bone metastasis in patients with nasopharyngeal carcinoma after radiochemotherapy[J].Chin J Radiat Oncol,2013,22(4):299-302.DOI:10.3760/cma.j.issn.1004-4221.2013.04.010. [16] Yoon A,Choi CH,Kim TH,et al. Bone metastasis in primary endometrial carcinoma:features,outcomes,and predictors[J].Int J Gynecol Cancer,2014,24(1):107-112.DOI:10.1097/IGC.0000000000000015. [17] Brown JE,Cook RJ,Lipton A,et al. Serum lactate dehydrogenase is prognostic for survival in patients with bone metastases from breast cancer:a retrospective analysis in bisphosphonate-treated patients[J].Clin Cancer Res,2012,18(22):6348-6355.DOI:10.1158/1078-0432.CCR-12-1397. [18] Asahara T,Dohi K,Hino H,et al. A case of hepatocellular carcinoma with bone metastasis responding to radiotherapy after successful hepatectomy of primary lesion[J].Hiroshima J Med Sci,1999,48(1):35-39. [19] Healey JH,Brown HK.Complications of bone metastases:surgical management[J].Cancer,2000,88(12 Suppl):2940-2951. [20] Imamura H,Masutani S,Tatsuta M,et al. A case report of successful transcatheter arterial embolization therapy for osseous metastasis of hepatocellular carcinoma[J].Gan To Kagaku Ryoho,2000,27(12):1941-1946. [21] Serafini AN.Therapy of metastatic bone pain[J].J Nucl Med,2001,42(6):895-906. [22] Meeuse JJ,van der Linden YM,van Tienhoven G,et al. Efficacy of radiotherapy for painful bone metastases during the last 12 weeks of life:results from the Dutch Bone Metastasis Study[J].Cancer,2010,116(11):2716-2725.DOI:10.1002/cncr.25062.
2017, Vol. 26 
